NCT07259356

Brief Summary

In the course of a cross-over study design, 12 patients with hemophilic arthropathy will perform a training load on the knee extensor muscles. The subjects will each perform one intervention with blood flow restriction and one with a Sham-BFR intervention.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2024

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 13, 2025

Completed
7 months until next milestone

First Posted

Study publicly available on registry

December 2, 2025

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

December 2, 2025

Status Verified

May 1, 2025

Enrollment Period

1.4 years

First QC Date

May 13, 2025

Last Update Submit

November 26, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain threshold

    Pain threshold measurement (PTT): The test determines the amount of pressure (in kg) over a given area in which a steadily increasing nonpainful pressure stimulus turns into a painful pressure sensation.

    Pre- (Baseline, before Exercise) to immediately Post-Intervention (after the exercise training intervention) and 24 hours after intervention

  • Quality of Life Score

    Hemophilia Joint Health Score

    Pre- (Baseline, before Exercise) to immediately Post-Intervention (after the exercise training intervention) and 24 hours after intervention

Study Arms (2)

Control Condition

ACTIVE COMPARATOR

Sham-BFR Leg Press Exercise

Device: Control

Intervention Condition

EXPERIMENTAL

BFR Leg Press Exercise

Device: BFR Exercise (50% of the LOP) while Leg Press Exercise (4 Sets, All out)

Interventions

ControlDEVICE

Sham-BFR Exercise (20mmHg) while Leg Press Exercise (4 Sets, All out)

Control Condition

BFR Exercise (50% of the LOP) while Leg Press Exercise (4 Sets, All out)

Intervention Condition

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with haemophilia
  • Ability for an exercise intervention

You may not qualify if:

  • Sickle Cell Anemia
  • Intravascular stents/bypasses
  • Open Wounds/Infections of the lower extremity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Bonn

Bonn, North Rhine-Westphalia, 53127, Germany

Location

MeSH Terms

Conditions

Hemophilia A

Condition Hierarchy (Ancestors)

Blood Coagulation Disorders, InheritedBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesCoagulation Protein DisordersHemorrhagic DisordersGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicipal Investigator

Study Record Dates

First Submitted

May 13, 2025

First Posted

December 2, 2025

Study Start

August 1, 2024

Primary Completion

December 31, 2025

Study Completion

March 1, 2026

Last Updated

December 2, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations